covi-vac
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 11, 2020 (NCT04619628)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- SARS-CoV-2Immunity, active
SARS-CoV-2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05233826 | Phase 1 | Apr 14, 2022 | Codagenix, Inc |
| NCT04619628 | Phase 1 | Dec 11, 2020 | Codagenix, Inc, hVIVO Services Limited |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Codagenix, Inc | For profit | 2 | 2 | 1 | 2020 |
| hVIVO Services Limited | For profit | 1 | 0 | 1 | 2020 |
2 organizations
Page 1 / 1